Cabenuva is a long acting HIV treatment that combines cabotegravir and rilpivirine and is given by injection under healthcare supervision. Understanding its potential side effects and safety considerations can help people follow treatment appropriately. Injection site reactions such as pain, swelling, redness, or tenderness are commonly reported, while some people may experience headache, fatigue, fever, nausea, or dizziness. Maintaining scheduled injections is particularly important because missed doses can affect medication levels and HIV treatment effectiveness. Healthcare providers also review other medicines for possible interactions and monitor overall treatment response.
Cabenuva is a long acting HIV treatment that combines cabotegravir and rilpivirine. It is administered as injections rather than taken as a daily oral HIV regimen. Understanding possible side effects, treatment schedules, precautions, and monitoring needs can help people make informed decisions about their HIV care. Cabenuva is prescribed for certain adults and adolescents with HIV who meet specific treatment requirements. Like other medicines, it can cause side effects, and healthcare professionals consider medical history, current medicines, HIV treatment response, and other factors when determining whether it is appropriate.
Cabenuva is generally administered by a healthcare professional. Injection site reactions are among the most frequently reported effects. These reactions may include pain, tenderness, swelling, redness, itching, or a small lump where the injection was given. Such reactions can vary in severity and often improve with time. Other reported effects may include headache, fever, fatigue, muscle pain, nausea, dizziness, or sleep-related changes.
People receiving Cabenuva should discuss unusual or persistent symptoms with their healthcare provider. Medical attention may be important when symptoms are severe, unexpected, or suggest an allergic or other serious reaction.
Common considerations include:
Injection site pain, swelling, redness, or tenderness
Headache, fatigue, fever, or muscle discomfort
Nausea or dizziness in some people
Possible interactions with other medicines
The importance of maintaining scheduled injections
Monitoring for symptoms that may indicate a serious reaction
Cabenuva is not appropriate for everyone. Certain medicines can affect how cabotegravir or rilpivirine work, so healthcare professionals review medications and supplements before treatment. People should not stop or change HIV treatment without discussing it with their healthcare provider.
One potential advantage of long acting HIV treatment is that it can reduce the need for daily oral medication for people who are eligible for the regimen. However, maintaining the injection schedule is an important part of treatment. Missing scheduled injections can increase the risk of reduced medication levels and may contribute to HIV developing resistance to treatment.
Healthcare providers may recommend oral medication in certain circumstances when an injection cannot be received on schedule. The appropriate approach depends on the individual's treatment plan and timing of the missed dose.
Important safety practices include:
Attend injection appointments according to the prescribed schedule.
Tell healthcare professionals about all medicines and supplements being used.
Report persistent or severe side effects.
Discuss pregnancy, breastfeeding, or plans for pregnancy with a healthcare provider.
Do not discontinue HIV treatment without medical guidance.
Keep regular appointments for HIV monitoring and overall healthcare.
Follow instructions provided by the prescribing healthcare professional.
Cabenuva does not cure HIV. Effective antiretroviral treatment can help suppress the virus and support long-term health when used appropriately. Treatment decisions should be individualized and based on medical guidance, laboratory results, previous treatment history, and other relevant factors.
Understanding both the benefits and potential risks of long acting HIV treatment can help people participate more confidently in decisions about their care. Anyone experiencing concerning symptoms or difficulty maintaining injection appointments should contact their healthcare provider promptly. This information is educational and is not a substitute for individualized medical advice, diagnosis, or treatment.